Opella's New Owners: CD&R and BPI Jump In
Opella, the maker of popular French painkiller Doliprane, is changing hands. U. S. private equity firm Clayton Dubilier & Rice (CD&R) has stepped up to take a majority 51% stake in the company. But they won't be the only new faces. The French government, through the Public Investment Bank (BPI), is